4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001209191-20-055572
10% owner bought 200,000 shares at $15.00 ($3,000,000)
- 10% owner acquired 2,414,563 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S 10% owner | 2020-10-20 | Conversion | +2,414,563 | 2,414,563 | D | ||
| Novo Holdings A/S 10% owner | 2020-10-20 | Purchase | +200,000 | $15.00 | $3,000,000 | 2,614,563 | D |
| Derivatives | |||||||
| Novo Holdings A/S 10% owner | 2020-10-20 | Conversion · SERIES A CONVERTIBLE PREFERRED STOCK | −1,609,493 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2020-10-20 | Conversion · SERIES B -1 CONVERTIBLE PREFERRED STOCK | −563,851 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2020-10-20 | Conversion · SERIES B -2 CONVERTIBLE PREFERRED STOCK | −241,219 | 0 | D | ||
| Open-market purchases · 200,000 sh · avg $15.00 · $3,000,000 | |||||||
Loading xslF345X03/doc4.xml…